Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study proposes to evaluate the process and outcome of an implementation program designed to implement the American College of Sports Medicine (ACMS)-recommended exercise assessment, advice, and referral instruction as standard practices in routine cancer care.
This study aims to test whether using implementing strategies (audit, feedback, facilitation, and adaptable workflow) to adopt the systematic FitARise protocol increases the proportion of eligible patients assessed, advised, and referred compared to control with the availability of the protocol, but without implementation strategies. This study hypothesizes that implementing strategies to promote the protocol's adoption will increase the proportion of eligible patients assessed and advised by oncologists and the proportion of patients referred to the JCICC exercise-based weight management program. For process evaluation, this study aims to use qualitative methods to assess the experience and response to the implementation program. The primary outcome (the reach measurement) is the percentage of eligible patients assessed, advised, and referred based on predefined BMI scores.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Implementation condition | Experimental | Under implementation conditions, the FitARise protocol will be implemented in routine oncological clinics using 4 implementation strategies, including audit, feedback, facilitation, and adaptable workflow at the beginning of the study. |
|
| Control condition | No Intervention | In the control condition, the clinical outpatient operation is performed as usual. The screening tool and referral forms will be provided to the study sites and clinicians are encouraged eligible patients to adopt the FitARise program. Patients referred to JCICC will be managed following the predefined clinical pathway triage system. A briefing session about the purpose of the implementation program and the introduction of the FitARise protocol will be given to the staff at each study unit before the start of the first 4-months control condition. The briefing session will be recorded for the purpose of fidelity assessment. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 3-step Assess-Advice-Refer | Behavioral | Four implementation strategies will be conducted individually for each of the study unit at the timepoint when the study unit is being randomly allocated to the implementation condition. For each study unit, all site facilitators will first receive a half-day training. Each study unit under the implementation condition will receive weekly audit and feedback reports to summarize the proportion of eligible patients, proportion of eligible patients being screened, proportion of patients appropriately referred to JCICC. The senior research assistant with a nursing background will receive training and mentoring from the PI and will be the guided facilitator. The guided facilitator will conduct weekly site visits to address operational issues arise during the implementation. Lastly, while the FitARise protocol is standardized and cannot be modified, the routine workflow for each study unit can be adjusted according to its context and resources. |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of eligible patients | The primary outcome (the reach measurement) is the percentage of eligible patients assessed, advised, and referred based on predefined BMI scores. | Pre- and post-implementation phase, up to 24 months |
| Measure | Description | Time Frame |
|---|---|---|
| Change in referral uptake | The secondary outcome is the uptake of the referral, i.e. the proportion of referred patients accepting the enrolment of the JCICC weight management program. This study also will examine the attendance rates of those enrolled in the weight management program. | Pre- and post-implementation phase, up to 24 months |
Not provided
Inclusion Criteria (Cancer patients):
Exclusion Criteria (Cancer patients):
Inclusion Criteria (Clinical staff):
- All clinical, medical or surgical oncologists at the study units during the study period.
Exclusion Criteria (Clinical staff):
- No exclusion criterial for staff.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Wendy Lam, PhD | Contact | +852 39179878 | wwtlam@hku.hk |
| Name | Affiliation | Role |
|---|---|---|
| Wendy Lam, PhD | The University of Hong Kong | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| KWH Department of Surgery | Hong Kong | Hong Kong |
All IPD that underlie results in a publication will be available from the PI upon reasonable request
Starting 6 months after publication
Information will be available from the PI upon reasonable request. The author to review requests is the PI.
Not provided
Not provided
This study will use a stepped wedge cluster randomized controlled trial design in which the intervention is introduced stepwise across study units . After obtaining the consent form from the 9 oncology units, they will be randomized to one of the three roll-out schedules with a 4-month duration each. All the study units will start the trial in a control condition (i.e., no implementation strategies used). At each time point, a new group of 3 study units will cross over from the control condition to the implementation condition, until all sites are receiving the intervention.
Not provided
Not provided
Not provided
Not provided
|
|
| PMH Department of Oncology | Hong Kong | Hong Kong |
|
| PYEH Department of Clinical Oncology | Hong Kong | Hong Kong |
|
| QMH Department of Clinical Oncology | Hong Kong | Hong Kong |
|
| QMH Department of Obstetrics and Gynaecology | Hong Kong | Hong Kong |
|
| QMH Department of Surgery | Hong Kong | Hong Kong |
|
| TMH Department of clinical oncology | Hong Kong | Hong Kong |
|
| YCH Surgery Department | Hong Kong | Hong Kong |
|
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009369 | Neoplasms |
| ID | Term |
|---|---|
| D001519 | Behavior |
Not provided
Not provided